{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:25:41Z","timestamp":1755797141965,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,18]]},"DOI":"10.7759\/cureus.90407","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:41:28Z","timestamp":1755535288000},"source":"Crossref","is-referenced-by-count":0,"title":["Scleromyxoedema and Thyroid Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Hajar","family":"El Hassani Taib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syrine","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem","family":"El Moustaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najoua","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Benzekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariame","family":"Meziane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2010.08.011","article-title":"Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study [Article in French]","volume":"137","author":"Le Moigne M","year":"2010","unstructured":"Le Moigne M, Mazereeuw-Hautier J, Bonnetblanc JM, et al.. Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study [Article in French]. Ann Dermatol Venereol. 2010, 137:782-8. 10.1016\/j.annder.2010.08.011","journal-title":"Ann Dermatol Venereol"},{"key":"ref2","article-title":"Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?","volume":"105","author":"Hazan E","year":"2020","unstructured":"Hazan E, Griffin TD Jr, Jabbour SA, Keller MS. Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?. Cutis. 2020, 105:E6-E10.","journal-title":"Cutis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2017.03.238","article-title":"Favorable evolution of Arndt-Gottron scleromyxedema under polyvalent immunoglobulins [Article in French]","volume":"38","author":"Garcia B","year":"2017","unstructured":"Garcia B, Lasek A, Modiano P. Favorable evolution of Arndt-Gottron scleromyxedema under polyvalent immunoglobulins [Article in French]. Revue de M\u00e9decine Interne. 2017, 38:A171-2. 10.1016\/j.revmed.2017.03.238","journal-title":"Revue de M\u00e9decine Interne"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti F","year":"2001","unstructured":"Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol. 2001, 44:273-81. 10.1067\/mjd.2001.111630","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14319","article-title":"Scleromyxedema","volume":"18","author":"Hoffmann JH","year":"2020","unstructured":"Hoffmann JH, Enk AH. Scleromyxedema. J Dtsch Dermatol Ges. 2020, 18:1449-67. 10.1111\/ddg.14319","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00017-7","article-title":"Diffuse cutaneous mucinoses","volume":"20","author":"Jackson EM","year":"2002","unstructured":"Jackson EM, English JC 3rd. Diffuse cutaneous mucinoses. Dermatol Clin. 2002, 20:493-501. 10.1016\/S0733-8635(02)00017-7","journal-title":"Dermatol Clin"},{"key":"ref7","article-title":"Cutaneous mucinosis associated with thyroid dysfunction","volume":"32","author":"Schaeffer D","year":"1983","unstructured":"Schaeffer D, Bruce S, Rosen T. Cutaneous mucinosis associated with thyroid dysfunction. Cutis. 1983, 32:449-52, 454, 456.","journal-title":"Cutis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2013.34165","article-title":"Scleromyxedema: a rare disorder and its treatment difficulties","volume":"30","author":"Koronowska SK","year":"2013","unstructured":"Koronowska SK, Osmola-Ma\u0144kowska A, Jakubowicz O, Zaba R. Scleromyxedema: a rare disorder and its treatment difficulties. Postepy Dermatol Alergol. 2013, 30:122-6. 10.5114\/pdia.2013.34165","journal-title":"Postepy Dermatol Alergol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01685.x","article-title":"Papular mucinosis associated with subclinical hypothyroidism: improvement with thyroxine therapy","volume":"20","author":"Martin-Ezquerra G","year":"2006","unstructured":"Martin-Ezquerra G, Sanchez-Rega\u00f1a M, Massana-Gil J, Umbert-Millet P. Papular mucinosis associated with subclinical hypothyroidism: improvement with thyroxine therapy. J Eur Acad Dermatol Venereol. 2006, 20:1340-1. 10.1111\/j.1468-3083.2006.01685.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962010000100014","article-title":"Papular mucinosis associated with hypothyroidism [Article in Portuguese]","volume":"85","author":"Volpato MB","year":"2010","unstructured":"Volpato MB, Jaime TJ, Proen\u00e7a MP, Gripp AC, Alves Mde F. Papular mucinosis associated with hypothyroidism [Article in Portuguese]. An Bras Dermatol. 2010, 85:89-92. 10.1590\/s0365-05962010000100014","journal-title":"An Bras Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2012.11125","article-title":"Successful intravenous immunoglobulin treatment of atypical lichen myxedematosus associated with hypothyroidism and central nervous system involvement: case report and discussion of the literature","volume":"17","author":"Macnab M","year":"2013","unstructured":"Macnab M, Kenny P. Successful intravenous immunoglobulin treatment of atypical lichen myxedematosus associated with hypothyroidism and central nervous system involvement: case report and discussion of the literature. J Cutan Med Surg. 2013, 17:69-73. 10.2310\/7750.2012.11125","journal-title":"J Cutan Med Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000498881","article-title":"Discrete papular lichen myxedematosus and scleromyxedema with hypothyroidism: a report of two cases","volume":"11","author":"Shenoy A","year":"2019","unstructured":"Shenoy A, Steixner J, Beltrani V, Gottlieb A. Discrete papular lichen myxedematosus and scleromyxedema with hypothyroidism: a report of two cases. Case Rep Dermatol. 2019, 11:64-70. 10.1159\/000498881","journal-title":"Case Rep Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1977.01640050144031","article-title":"Hypothyroidism and lichen myxoedematosus","volume":"113","author":"Archibald GC","year":"1977","unstructured":"Archibald GC, Calvert HT. Hypothyroidism and lichen myxoedematosus. Arch Dermatol. 1977, 113:684.","journal-title":"Arch Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.07.011","article-title":"Scleromyxedema","volume":"24","author":"Cokonis Georgakis CD","year":"2006","unstructured":"Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol. 2006, 24:493-7. 10.1016\/j.clindermatol.2006.07.011","journal-title":"Clin Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06710.x","article-title":"Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin","volume":"153","author":"Shergill B","year":"2005","unstructured":"Shergill B, Orteu CH, McBride SR, Rustin MH. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin. Br J Dermatol. 2005, 153:650-2. 10.1111\/j.1365-2133.2005.06710.x","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2065-5","article-title":"Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years","volume":"93","author":"Devos T","year":"2014","unstructured":"Devos T, Thiessen S, Cuyle PJ, Meersseman W, Delforge M. Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years. Ann Hematol. 2014, 93:1927-8. 10.1007\/s00277-014-2065-5","journal-title":"Ann Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14888","article-title":"Scleromyxedema treatment: a systematic review and update","volume":"59","author":"Haber R","year":"2020","unstructured":"Haber R, Bachour J, El Gemayel M. Scleromyxedema treatment: a systematic review and update. Int J Dermatol. 2020, 59:1191-201. 10.1111\/ijd.14888","journal-title":"Int J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000356469","article-title":"Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin","volume":"5","author":"Dolenc-Volj\u010d M","year":"2013","unstructured":"Dolenc-Volj\u010d M, Jur\u010di\u0107 V, Ho\u010devar A, Tom\u0161i\u010d M. Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin. Case Rep Dermatol. 2013, 5:309-15. 10.1159\/000356469","journal-title":"Case Rep Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02766.x","article-title":"Scleromyxedema with myopathy was successfully treated by thalidomide","volume":"23","author":"Wu MY","year":"2009","unstructured":"Wu MY, Hong JB, Yang CC, Hu SL, Liao YH. Scleromyxedema with myopathy was successfully treated by thalidomide. J Eur Acad Dermatol Venereol. 2009, 23:189-90. 10.1111\/j.1468-3083.2008.02766.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000452319","article-title":"Scleromyxedema without paraproteinemia: treatment with thalidomide and prednisolone","volume":"8","author":"Saniee S","year":"2016","unstructured":"Saniee S, Davarnia G. Scleromyxedema without paraproteinemia: treatment with thalidomide and prednisolone. Case Rep Dermatol. 2016, 8:327-32. 10.1159\/000452319","journal-title":"Case Rep Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386473-scleromyxoedema-and-thyroid-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:41:29Z","timestamp":1755535289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386473-scleromyxoedema-and-thyroid-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.90407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}